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Abstract
For the first time in a decade, the number of new human immunodeficiency virus (HIV)
diagnoses is higher for heterosexual people compared to gay and bisexual men (Florêncio, 2022).
Additionally, in the United States, the American Red Cross has declared a national blood crisis
due to the nationwide shortage of donated blood. During this crisis, charged with the new
information on HIV diagnosis rates, many advocates for the Lesbian, Gay, Bisexual,
Transgender, Queer (LGBTQ+) community question why discriminatory policy surrounding gay
and bisexual men donating still exist around the world. These policies are changing worldwide –
several European countries have lifted bans on gay men donating blood, such as the France
(however there are still conditions such as requiring a monogamous relationship). However, in
the United States, only gay and bisexual men who have been sexually inactive for 90 days are
able to donate blood. In Switzerland, they must be sexually inactive for one year. This study
aims to explore how policy surrounding blood donation is developed to study how health-related
policy in general is formulated. Because there is a discrepancy between the restrictions on blood
donation and the true risk of HIV transmission in blood donations used for transfusions, there
must be factors beyond pure science influencing policy. This paper observes the following
factors as influences in health policy beyond pure science: historical context, technologies, and
public perception.
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Introduction
Blood donation, today, is a vital procedure that is volunteer based. National blood
donation schemes create a process that involves many actors. At the most basic level, there is a
blood donor and there is a transfusion recipient. Donors are screened through questionnaires and
medical experts to ensure safe blood is collected and disseminated. Further testing is done, again,
for the purpose of recipient safety. The questionnaires for and general evaluation of the donor
follow guidelines set by specific policy making entities. Blood donation policy falls into the
category of health policy. The policy-making entities use a variety of resources to create
recommendations and guidelines that claim to keep safety at the core of their decisions. As a
general standard, the policy-making entities allegedly use scientific knowledge to make these
guidelines and adjust guidelines in response to evolving science.
However, there are many other factors that influence policy. To investigate what kinds of
factors have an impact on health policy, this paper aims to investigate how blood donation policy
has changed regarding male donors who have sex with men in three countries where the current
policy differs. In the United States, male donors who have sex with men are only eligible to
donate if they have not had sexual contact with another man in the past 3 months. In France, this
kind of “deferral” policy has been lifted, and restriction on blood donations are based on risk
behavior rather than sexual orientation. Finally, in Switzerland, male donors who have sex with
men are currently ineligible to donate blood if they have had sexual contact with another man in
the past year.
The objective of this study is to analyze three factors that influence health policy and the
impact they have, including what biases they hold. Historical context, receptions to technological
growth, as well as public perceptions all have an impact on policy creation. This paper dives into
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how these three factors have influenced blood donation policy for men who have sex with men in
the United States, France, and Switzerland.
It is expected that health policy is created based on scientific evidence and without bias.
Therefore, identifying factors beyond pure science that have an impact on policy and hold
potential bias helps create a critical dialogue on how policy is created. Blood donation policy has
effects beyond recipient safety. Of course, safety of the recipient should be considered the
number one safety, but unnecessarily strict policy can harm communities. Policy creation,
therefore, should be based on science rather than a reaction to public fears and demands.

Research Methodology
This research was developed through the combination of a review of the existing
literature, current and prior guidelines regarding blood donation eligibility, as well as qualitative
interviews with representatives from LGBTQ+ organizations. Overall, the research combines
qualitative analyses from both the relevant sources and the interviews conducted.
The aim of the literature review was to identify key factors that could influence blood
donation policy, and health policy. Three key factors were identified through analyzing current
and past guidelines and recommendations released by the United States, French, and Swiss
governments along with reactions to these guidelines. Press releases about policy changes were
included in the study and provided meaningful insight into how governments and policy-making
entities formulated any changes to policy. New sources, both from the past and recent times,
regarding policy decisions were also analyzed, as they represent general reactions to blood
donation policy and potential changes.
Furthermore, research on the policy making entities in each of the countries were
included in this process to garner an understanding of their operations and where potential biases
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could exist. Once the policy making entities were identified, it was critical to evaluate their
mission statements as well as the relevant guidelines and recommendations they have published.
Administrations of these organizations during relevant changes represent key stakeholders that
may hold personal biases as well. Therefore, personal statements were identified through press
releases, social media posts, and statements made to news sources.
The policy-making entities included the national governments in the United States,
France, and Switzerland. Specific sub-sections of the government play more of a role in creating
policy for blood donation. Some of the organizations that were identified included the Food &
Drug Administration and the Centers for Disease Control in the United States, the Ministry of
Health and Santé publique France in France, and Blood Transfusion Service of the Swiss Red
Cross Ltd and Swissmedic in Switzerland. Other organizations do not necessarily have the direct
power to make decisions but have issued statements on their perspective on the issue. These
organizations include the American Red Cross and the European Court of Justice. Once the
organizations were identified, published recommendations and guidelines regarding blood
donation by the respective organizations were able to be included in the literature review.
Ideally, to get a better understanding of how decisions are made behind closed doors, key
stakeholders within the policy-making institutions would be interviewed. To obtain this
perspective, representatives from the organizations were reached out to via contacts on the
corresponding websites as well as through LinkedIn. An overwhelming majority were unable to
complete the interview request, as instead referenced official documents and statements that
were release in lieu of an interview. The rest of the contacts did not respond.
The lack of personal communication with key stakeholders in the policy-making entities
led to relying on voices from other stakeholders within blood donation policy creation. LGBTQ+
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communities have been harmed by the policies, claiming that they are not medically founded. To
understand more about this claim, LGBTQ+ organizations and members of the LGBTQ+
community within the three countries were contacted for interviews. These interviews primarily
aided in formulating the analysis on the impact that perception plays in policy creation.
Additionally, some of the organizations have worked with policy-making entities and have
insight into how those conversations are conducted.
The interviews quoted in this paper are from a representative from the Switzerland Pink
Cross, the national umbrella organization for gay and bisexual men, and a member of the
LGBTQ+ community in the United States. Roman Heggli is the managing director of the Pink
Cross. After reaching out via email, Roman responded and an interview was set up for April 12,
2022. The interview took place over Zoom and verbal consent was retrieved before asking
questions about his organization as well as his thoughts on the existing blood donation policy in
Switzerland. John Smith is a member of the gay community and asked for his identity to be kept
anonymous for the interview. The meeting took place on April 18, 2022 and verbal consent to
record the interview was obtained before asking about the blood donation policy in the United
States and his thoughts about the existing policy.

Literature Review
The identified factors that influence health policy are based on perspectives from existing
literature, including theory about the influence of history, technology, and cultures/perspectives.
Where there is a lack of sources that reference blood donation policy for the MSM population,
there is significant information on the policy creation process and the factors that influence this
process. In this section, the main literature focusing on theory used in this paper are described.
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Literature on the Impact of History
History plays an influence role in creating policy. Its impact comes in many different
forms, from policy makers trying to avoid past errors to public fear of history repeating. The
literature on the relationship between history and health policy demonstrates that effect is not
necessarily positive or negative, but merely demonstrates that it plays a role. History imparts
“moral and ethical principles” on a population (Berridge, 2008). It helps form their perspective
on certain conditions and standards. However, there is a concern that the value of history cannot
be tested the same way you test the value of scientific discovery. It is not an influence that
provides “yes” or “no” answers, rather, it allows for critical thinking and open dialogues. When
considering history, it is relevant to consider the impact of past policy. The value of history
diminishes if organizations are unable to admit prior errors and be willing to learn from them.
Berridge, in “History Matters? History’s role in Health Policy Making,” describes how
politicians use history in debates and arguments. Within her paper, there are perspectives from
both sides, one stating that history has a role in policy making and that it is a form of evidence,
and the other stating that history has no formal role in the health policy sector. However, her
findings support the fact that history is used in policy making. Some of the uses of history cited
in her paper are ones that allow policy makers to be critical and learn from previous policies and
their effect. On the other hand, there were also instances where policy makers were more
inclined to “invoke history” over other significant evidence (Berridge 2008).
Part of the criticism of the role of history in policy making is that the influence of history
is not made clear in official policy. This is, in part, because “when the works of historians have
been used by policy makers, they are not cited” (Adu-Gyamfi et al., 2016). The existing
literature argues that though history should not be neglected in policy creation, it should be used
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in combination with relevant scientific information. Furthermore, history is “potentially
valuable” but it should be “fairly recent” to include in policy-making decisions (Adu-Gyamfi et
al., 2016).
Based on the existing literature on the relationship between history and policy, this paper
attempts to analyze if the historical context used to justify blood donation restrictions is valid and
supported by scientific knowledge. Based on the theory presented by the existing literature,
history can be used out of context to support political gain rather than for keeping the health of a
nation at the core of decisions. Therefore, there may be biases when using history to make health
policy decisions.

Literature on the Impact of New Technology
Ideally, innovation and policy would go hand in hand. As scientific knowledge grows and
relevant technology is invented, policy can be changed as risks change. Naturally, there is a
delay in between innovation and policy as evidence is gathered. Therefore, the existing literature
regarding innovation and policy is focused on what this delay looks like. There is no specific
timeline, as new technology varies quite a bit, but the time difference between available
technology and consequent policy implementation can be analyzed to be necessary or not.
British scientist, CP Snow, identified the disconnect between science and the humanities
in his 1959 essay, “The Two Cultures.” He identifies the split as detrimental and calls for more
communication between these two seemingly separate worlds. The impact of the disconnect is
that “articulation with public policies at the national level are not adequately resolved, therefore
local capabilities remain hidden, and the technologies developed encapsulated” (Bianchi, 2013).
Furthermore, unwarranted delays in the use of technology can be harmful. For instance,
regarding energy innovation, the lack of funds to support new sustainable technology is causing
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negative effects on the environment. The evidence that a problem exists is available and the
technology to present a solution to the problem is similarly available. Schiener (2019) argues that
bridging the gap between technology and policy making, therefore, is vital. Prior health crises
have demonstrated how policy makers have excluded medical experts in their decision-making
process and today the exclusion is with technologists. The reality is that technologists and
policymakers rely on one another regardless of the lack of a formal relationship (Chavern, 2019).
Policymakers must stay informed and act accordingly in response to new technology. While a
slight delay is understandable if one is to rely on scientific evidence before making changes,
longer periods are unacceptable.
Regarding this paper, literature on the development of new technologies for blood
screening and disease prevention and treatment were also analyzed. The literature on this topic
was objective and focused on the scientific findings. The most relevant part for this paper was
the date of publishing and the validity of the research methodology. Using the existing literature
on the relationship between technology and policy, the difference in time between evident
scientific knowledge and policy change were evaluated for any evidence of biases.

Literature on the Impact of Perception
The main concepts to understand the impact of perception on policy creation is from
“The Role of National Culture in Shaping Public Policy” by Dr. Katherine Danielle. In this
analysis, Danielle provides examples of how policy has been impacted by national culture. It
provides a background understanding for why policy can vary between countries when the
scientific knowledge stays consistent. She argues that a “typical narrative” can influence the
course of policy creation (Danielle, 2014). Throughout the paper, there are case studies of the
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role that culture has played in policy creation, providing background context of the role culture
plays. She does not attempt to support or reject the influence.
While Danielle provides an objective lens on how culture impact policy, Muers (2019)
discusses how culture should be kept at the heart of policy making decisions in “Culture, Values,
and Public Policy.” While this makes sense for social policy decisions, it may not be the most
reliable factor for policies in the health sector. Muers concedes that the central role of culture
should be “nuanced or altered for particular contexts” (Muers, 2019). Policymakers are regarded
to be reactionary, then, as they create policy that reflects existing ideologies. Pre-dominant
cultural attitudes may be backwards in nature, however, and relying on general perception can,
therefore, be harmful. Additionally, cases in which fear of public reaction drives policy creation
over general scientific knowledge undermines the position of policy-making entities and the
objective position from which they stand.
The existing literature demonstrated that culture has an impact on many other aspects of
society that can, in turn, influence policy. For example, the media plays a role in how people
react to policy (Berridge, 2008). Media is considered a reflection of the audience’s perception as
content creators mainly focus on retaining viewers. Overall, the existing literature on the
connection between public policy and culture or public perception demonstrates that there is a
significant impact of perception in policy. This paper, then, aims to evaluate whether the impact
of perception for policy regarding MSM blood donations is valid in the United States, France,
and Switzerland.

Analysis
Historical Context
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The first transfusion of human blood occurred in London in 1818 by James Blundell.
Afterwards, the first blood bank, a systematic collection of blood, was established in 1932 in
Leningrad. Blood donation, in a systematic fashion, is crucial in the medical world. It helps
patients survive surgeries, cancer treatment, chronic illnesses, and traumatic injuries. The
systematic aspect is essential as it is important to use correct matches for blood transfusion and
blood must be tested for transmittable diseases. Safety, primarily of the recipient of blood
transfusions, has been the core of creating policy around blood donation. Therefore, the
emergence of the global AIDS (acquired immunodeficiency syndrome) epidemic in the 1980s
represented a shift in blood donation criteria.
The fear of the condition along with the primary affected demographic during this time,
men who have sex with men (MSM), led to a permanent ban on MSM from donating blood in
many countries, including all three included in this study. At the time, “these precautions were
deemed necessary due to the lack of testing for the AIDS pathogen” (Beattie & Mucklow, 2018).
However, by 1984, French and American scientists identified human immunodeficiency virus
(HIV) as the cause of AIDS. With this discovery, scientists were able to develop tests quickly.
The early tested used the enzyme-linked immunosorbent assay (ELISA) method which focused
on identifying antibodies to detect HIV.
The ELISA method had a window period, the time after infection and before
seroconversion, that could be three to six months (Alexander, 2016). The delay in identifying the
infection could be reason for deferral periods. However, the shift from a permanent ban to 12month deferrals (which the United States, France, and Switzerland all shifted to) happened much
after the early tests were developed. The tests were developed in 1985 and have consistently
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been improving since then. The permanent ban was lifted, in all three countries, well into the 21st
century.
Policy Creation Entities
Understanding the entities that create policy provides valuable insight to the biases that
can exist in policy making. Furthermore, the evolution of the organization and actors involved in
blood donation policy creation provides additional insight into the historical context for blood
donation policy.
United States
In 1940, the United States government established a national blood collection program. It
originally grew as the Red Cross created programs to collect blood for the US military, but the
Red Cross began blood programs for civilians in 1948. By 1972, the Red Cross had called for a
national blood policy and in the same year, the Food & Drug Administration (FDA) began
regulating all existing blood and plasma centers. Blood supply safety is a responsibility shared
by many actors but the FDA gas regulatory authority over all blood products. The Centers for
Disease Control and Prevention (CDC), on the other hand, is tasked with surveillance of health
risks within the blood supply. The National Institutes of Health (NIH) provides support for the
national blood system through research.
At the beginning of the AIDS epidemic, the FDA-approved changes to ensuring safe
blood collection did not include questions about sexual practices, there was still a level of
uncertainty and a lack of consensus about the magnitude of threat certain sexual practices
involved. Overall, there was a general blind acceptance that the risk of AIDS was low in terms of
blood transfusion.
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Before there was a federal policy codified by the FDA, organizations had already
implemented donor screening measures and excluded those who were considered high risk,
which was primarily MSM in the 1980s. Organizations such as the CDC and the American
Association of Blood Banks had issued statements with deferral recommendations. They also
recommended surrogate testing, which was not as intensely followed by collection agencies. The
FDA released guidelines asking men who has sex with multiple mal partners to refrain from
donating blood in 1983. In 1986, the guidelines became mandatory exclusions of men who have
had sex with men in the past ten years. The FDA finally recommended the lifetime ban in 1992.
The FDA recommendations did not follow the progression of scientific knowledge nor
available technology. The initial recommendation can be seen as a reactionary decision made
when there was still very little knowledge about HIV. However, both the initial ban and the
lifetime ban came after testing technology had been developed. The FDA was highly criticized at
the onset of the epidemic for failure to take action to protect the blood supply, leading to
individuals with hemophilia contracting AIDS and spreading it to their family members
(Harmon, 2022). “Innocent” people who relied on proper safety measures for blood reception
were harmed, and the FDA was to blame as the primary holder of responsibility in terms of
blood products. The intensity at which they created policy meant to protect the blood supply
from HIV may have been a political move to demonstrate the authority and reliability the FDA
possessed, a move to reinstate their position in US health policy and regain public trust.
There are a variety of voices that are contributing to changes in blood donation policy in
the United States. For example, the American Red Cross states officially on their website that
they recognize “the hurt [the MSM] policy has caused to many in the LGBTQ+ community” and
are committed to working with relevant partners to create blood donation criteria that is not
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determined by sexual orientation (The American National Red Cross, 2022). The CDC has also
stated that the FDA’s policies do not match with the existing technology (Centers for Disease
Control, 2019). However, all blood collection organizations are regulated by the FDA in the
United States, making the final say theirs.
France
Much like the United States, the French government instituted a total ban on MSM giving
blood in 1983 in response to the AIDS epidemic. Additionally, it came after hundreds of people
died in the 1980s after receiving blood with HIV from the national blood transfusion center. The
1983 mandate was further reinforced by successive texts from 1993 and 1997. The decree was
formalized in 2009. The reaffirmations were justified by the increased risk of HIV seen in MSM
compared to other sexual relationships. The ban was lifted in 2016, a response to the years of
campaigning by LGBTQ+ rights activists.
The Ministry of Health in France is the body that makes decisions pertaining to blood
donation policy. The Santé publique France (SpF) is the French public health authority and
conducts studies used to make decisions for public health. The SpF carried out numerous studies
after the 2016 12-month deferral was instated, demonstrating that including MSM donors did not
increase the risk of HIV infection. Back in 2012, Marisol Touraine pledges to life the ban on
blood donation for MSM (Solidarites-Sante, 2015). However, to respect safety of recipient,
France’s introduction of MSM blood into the national supply was done in stages. The goal was
to introduce the 12-month deferral and study the changes to the blood supply. This scientific
process was adopted in a bill to modernize the French health care system and was voted
unanimously in the National Assembly.
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The Ministry relied on recommendations from the National Agency of the Safety of
Medicines and Health Products as well as the Institute for Health Surveillance in response to the
decision made by the European Court of Justice. The European Court of Justice, based in
Luxembourg, ruled that governments had the right to ban (or restrict) MSM blood donors given
that they could provide evidence that it was the best way to limit the risk of HIV infection
(Solidarites-Sante, 2015). Special projects were mandated to gather scientific evidence on if
MSM bans were, in fact, the best way to limit the risk of HIV in blood.
The French government, since 2015, has had the mandate to end the exclusion of MSM
from donating blood while considering recipient safety. The integration of a 12-month deferral
was a move mirroring other western countries but was instated with the intent to observe changes
and act according to findings. In stating so, the French government demonstrated a commitment
to scientific knowledge as the backing behind health policy decisions. Though continuing with a
deferral based on sexual orientation is a product of historical precedent, it was done this way to
observe differences in risk with a scientific basis for further change.
Switzerland
In Switzerland, the original guideline that barred MSM from donating states that any man
who has sex with a man cannot donate. This ban was implemented in 1977, and officially made
law in 1988, prior to the discovery of HIV, and was finally lifted after 40 years on July 1, 2017.
Instead, an abstinent period of 12-months was introduced for MSM and is currently in place.
Compared to the United States and France, this change in policy came much later.
Policy around blood donation is created through the interaction of a variety of actors.
Swiss transfusion medicine is managed under the Blood Transfusion Service of the Swiss Red
Cross Ltd (BTS SRC). BTS SRC publishes mandatory guidelines for all regional blood
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transfusion services. Swissmedic covers all aspects of transfusion medicine, from donor selection
to blood transfusion. Additionally, all blood components are considered drugs and, therefore,
mist also follow all legal requirements, giving Parliament a say in creating the policy as well.
In 1949, the Swiss Red Cross (SRC) set up a central location for preparing blood
products and in 1951 the Swiss government mandated the SRC to supply the population with
blood products both in normal and war situations. In 1994, the government consolidated the
blood transfusion centers and they were led and mandated by the SRC and the mandatory
guidelines they create. In 2002, the Law of Therapeutic Products defined criteria for donor
selection, mandatory tests, and record keeping. It also set up the federal drug regulatory agency,
Swissmedic.
Swissmedic, in the past, has vetoed multiple attempts to discuss the issue of the blood
donation ban. This use of power has prevented key voices from even having a say in the policy.
At the same time, prior to moving to the 12-month deferral, in 2016, the director of the BTS
SRC, Rudolf Schwabe, made statements supporting creating policy that is based on habits rather
than sexual orientation (Romy, 2017). The difference in positionality of Swissmedic and BTS
SRC raises questions about the basis of Swissmedic’s policy. Both organizations have similar
interests, a safe blood supply, yet different approaches to this safety.
Impact of History
Though the fear of HIV contaminating the available blood supply was justifiable
according to the existing literature reviewed in this paper, the fear was not abated despite the
changes to prevention and treatment of AIDS/HIV. Though there were scientific advancements
that could have allowed MSM to donate blood and contribute to national supplies, there was no
revisions to existing policy.
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At the beginning of the AIDS epidemic, diagnoses were predominantly in MSM,
individuals from Sub-Saharan Africa, and non-medical intravenous drug users. This affected the
perception of the disease, equating certain marginalized groups with AIDS/HIV. Additionally,
these groups continued to have higher rates of HIV diagnoses for years. Furthermore,
proportionally, rates are higher in MSM populations compared to many other groups still today.
Because this connection, the general view that MSM means accepting the risk of HIV
contraction, has been persistent, history creates barriers in amending policy.
In general, policies are easier to create than to withdraw. Support must be collected, and
the policy must be justified in one way or another to be implemented. On the other hand,
withdrawing policy involves admitting fault and rejecting prior support. In other words, it can be
seen as accepting a certain kind of defeat and supporting for change, a concept that is quite
difficult in the political world. Therefore, “the introduction of new technologies and the
evolution of scientific consensus on both biological and social harm outpace policy change in
many instance” (Wilson et al., 2014). For example, in France, collecting evidence that MSM
donors do not pose a significant threat to the national blood supply was not the last step, the 2009
decree had to first be amended, which required the contributions of the scientific community as
well as political backing.
The pain felt during the AIDS epidemic only adds to the hesitancy in bringing change to
policy. Tragic history creates a narrative that harms the ability to change policy despite the
emergence of new evidence and scientific knowledge. A simplified understanding of national
blood supplies can be stated as follows: AIDS/HIV contaminated the existing blood supply
during the epidemic, precautionary policy was created to protect recipients, the risk was
eliminated. With a successful policy implementation, it is easy to reject the fight for change and
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rely on precautionary policy rather than risk management. However, though it is understandable,
it fosters biases, and the health system is not one that should be biased. Historical context should
be considered in creating policy, but one cannot rely on the past to create policy of the future.
At the height of the epidemic, it made more sense to have a blanket policy that prevented
the population at risk from donating. With a lack of understanding of the cause behind AIDS and
without reliable testing, precautionary policy was the only option. Even then, however, there was
backlash from the MSM community, citing discrimination. But, to many health professionals, the
resulting stigma and discrimination was a necessary cost to protect the blood supply. Once there
was a better understanding of AIDS/HIV, advocates argue that there could have been a switch to
criteria for risk behavior, i.e. sexual contact with multiple partners regardless of sexuality, rather
than specific populations. Again, though, equating MSM, and other specific groups, to HIV, an
idea persisting from the 1980s, prevents this change in many countries, including the countries
included in this study.

New Technologies
If HIV and AIDS were still understood and treated the same way they were in the 1980s,
MSM donors could still be considered a threat to national blood supplies. However, much has
changed since the onset of the epidemic. Specifically, scientific discoveries and technological
growth have changed the way blood is tested and the accuracy at which is tested. Additionally,
thanks to advancements in preventative care, HIV diagnoses can be prevented.
Testing technology
The first HIV antibody test was developed in 1985. It was able to show positives 6 to 12
weeks post infection but there was a high rate of false positives. Because the test was designed to
screen blood products, high false positives reflect the interests of protecting the blood supply
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where a “better safe than sorry” mindset prevailed. Second- and third- generation HIV tests
reduced the testing window to about 3 weeks post infection. At this time, many nations,
including the United States, France, and Switzerland, continued requiring a complete ban of
MSM donors and continued for at least another decade. Early tests only screened for one of two
HIV agents, but, by 1992, antibody tests could identify the second HIV agent as well (Fabry,
2016).
By the late 1990s, testing began to combine antibody and antigen detection, resulting in a
reduced test-window (two weeks) and had 100% sensitivity and >99.9% specificity. At this time,
a duplex nucleic acid test (NAT) was developed and implement in most developed countries by
the early 2000s. These newer tests look for the virus itself, rather than the development of
antibodies. NAT closes the window period between infection and antibody detection, resulting in
a window period of 7 to 10 days. Because of the high sensitivity provided by ELISA, many
countries continue to use the anti-body method or some combination of the available tests.
The progress in testing clearly does not align with the timeline relating to easing
restrictions for MSM blood donation. The argument for exclusionary practices was because of
higher rates of HIV diagnoses within the MSM population. However, testing is widely accessible
to the MSM population, allowing individuals to monitor their own status in a timely manner.
Furthermore, because every donation is tested, more than once in some countries, for HIV,
restrictions on MSM do not reflect the state of technology today, or the state of technology
available two decades ago. Interestingly, there is a surety demonstrated at the national level
about these tests and the technology developed yet bans persisted. The misalignment of the trust
in the test and the ability of MSM to donate demonstrates that the policy did not rely on testing
ability. Furthermore, France’s removal of the ban does not align with any key change in the
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available testing technology. The change from the 12-month deferral in the United States to the
3-month deferral also does not match up with any clear change in testing requirements. These
decisions were made separate from scientific advancements.
In the United States, the FDA has established, after “careful evaluation of the available
data, including data regarding detection characteristics of [NAT],” that testing is sufficient to
allow MSM donors after 3-month abstinence period (US Food & Drug Administration, 2020).
This statement was part of the FDA’s revised recommendation released in 2020 as a reaction to
the demand for blood during the onset of the Coronavirus disease pandemic. However, data on
NAT did not change specifically during 2020, the safety and testing ability has consistently been
high for the past decade. The FDA did not create new policy recommendations after the release
of new, sufficient data. The data already existed, it was just accepted in 2020 because of the
demand, demonstrating how technology is not the driver behind changes to blood donation
policy.
It is important to note that testing is important for blood supply safety regardless of who
is donating. Though HIV was originally thought to effect only certain populations, the reality is
that there is a certain level of risk for everyone. In 2003, in New Zealand, a non-MSM donor was
identified as HIV positive and all previous blood donations by this individual were recalled
(despite prior negative results). This resulted in a financial loss of $4 million and surgery in
people with hemophilia was postponed (Bayor, 2015). As mentioned above, detection
technology has improved since 2003, but the fact remains that excluding MSM donors does not
definitely protect the blood supply and that testing is increasingly the best way to protect the
blood supply. Additionally, between 2002 and 2010 in Switzerland, there was one HIV-positive
donor of about 3,100,000 blood donations (again during a time with a permanent ban on MSM).
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Despite the low rate of HIV infected blood donors in Switzerland, this case proved that the
immense cost of testing is necessary.
Preventative Care
With a better understanding of HIV, there are clear ways to stay safe and take action to
prevent HIV. Abstinence is a main prevention strategy, which is reflected in the deferals used in
blood donation policy. However, there are many other ways to prevent transmission. Proper use
of condoms and HIV prevention medicines such as pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) are widely used. Practicing safe-sex and getting tested regularly are
important for HIV prevention. Additionally, if an individual is HIV-positive, there are many
actions that can help prevent transmitting the disease to others (Girard, 2014).
The widespread accessibility of preventative measures renders abstinence-based deferrals
contradictory. For instance, homosexuals who do not take PrEP but have been abstinent for three
months can give blood while those who do take it (and therefore have the least risk of
contraction) are unable to. However, taking medication to prevent HIV is currently a conditional
leading to deferrals for blood donation. Because testing looks for the presence of antibodies, the
use of PrEP may interfere with testing for HIV by delaying the presence of antibodies or
resulting in inconclusive results. However, by making this a condition, pre-donation
questionnaires are capturing part of the risk of HIV contamination without targeting specific
sexual orientation. A similar strategy could be used to evaluate other risky behavior.
PrEP and other preventative care has also reduced the threat of HIV transmission.
Therefore, with proper preventative care, long-term monogamous MSM relationships are at
similar levels of risk as another other monogamous relationships. With the widespread access to
preventative care and routine testing, the risk of HIV in the MSM population has had a severe
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decline. Though HIV is still a major public health concern, more and more studies demonstrate
that risk is more associated with sexual behavior rather than sexual orientation.
Basing blood donation policy on the current technology does not lend itself to
differentiating by sexual orientation. Even if MSM are still considered a threat to blood supplies
because of higher rates of HIV, the window period is much less than the deferral periods in the
United States and Switzerland. The international standard for detention of infectious disease is
double the window period, following an ultra-cautious model meant to respect the safety of
blood transfusion recipients (Steele, 2020). Double the window period of the test used by the
United States, France, and Switzerland is still less than a month, rendering very little explanation
for a 3-month deferral in the United States and even less in Switzerland.

Perception
According to Katherine Daniell’s 2014 literature review for the Australian Nations
University, national culture plays a significant role in shaping public policy. In terms of health
policy, which, in its purest form, would be based on scientific knowledge and medically valid,
there she mentions how culture plays a role as well. This influence, in part, can help explain how
different countries vary in terms of policy.
An increasingly globalized world means that scientific knowledge is widely accessible
and is reviewed on a global scale. Additionally, political relationships between the United States,
France, and Switzerland are ones that foster healthy academic dialogue. However, the fact
remains that the policy around MSM blood donation is significantly different between the three
countries. The policy changed in similar ways, suggesting that, in the future, all three countries
could converge in policy making regarding blood donation. Nevertheless, the AIDS epidemic
effected these three countries at similar times at similar intensities.

22
The AIDS epidemic and its progression is relevant to observing changes in MSM blood
donation policy because the onset of bans and restrictions was in direct reaction to the epidemic.
If the epidemic influenced the United States, France, and Switzerland in similar ways, then the
fact that all three countries have different polices can be attributed to something outside the
impact of the AIDS epidemic. Though it is difficult to convey an entire nation’s attitude on
social issues, the following analysis uses specific cases to encapsulate the general feelings
toward MSM, and, consequently, their ability to donate blood, during certain time periods.
During the onset of the AIDS epidemic, when it became clear that the largest group
effected by the disease were MSM, the narrative used by the public was intensely discriminatory
and homophobic. In the United States, the epidemic started with the identification of 26
homosexual men with the disease. Various politicians shamelessly promoted that AIDS was a
punishment for homosexuality echoing an opinion felt by 43% of Americans in 1987 (Heimlich,
2020). MSM blood donations, consequently, were considered harmful contaminants to the
national blood supply.
In the United States, the epidemic started with the identification of 26 homosexual men
with the diseases. Additionally, AIDS being a blood-borne disease was partially confirmed by
transfusions recipients that were hemophiliac that were infected after receiving blood. Therefore,
it was perceived that the MSM community was harming the very group they thought they were
benefiting by donating blood.
Tests to identify HIV-positive blood was designed to screen blood products over
diagnosing AIDS. Here starts an interesting relationship between MSM and blood donation. The
safety of the blood supply was prioritized over high-risk populations during the height of the
epidemic. The best way to eliminate the threat of AIDS/HIV in donated blood is to address the
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epidemic and create policy to lower the rates for the entire population. However, this approach
was not taken as the political pressure built to prohibit certain “high risk” donors from donating
blood. Bans concerned gay organizations as they feared that it would add to existing
stigmatization and homophobic attitudes.
The association between AIDS and MSM started to shift when 14-year-old hemophiliac
Ryan White became the public face for HIV/AIDS. Due to the homophobic perception of the gay
community, the public was more receptive to Ryan White as a symbol of innocence for the
impact of HIV/AIDS. The use of Ryan White as a poster child represented the rejection of MSM
as innocent victims of the disease. These perceptions made a blanket ban on MSM donors more
acceptable and understandable. A combination of moral concerns and scientific knowledge
backed the original ban.
Ending sexuality-based blood donation policy in France does not necessarily correlate
with a significant shift in perceptions about the MSM population. In fact, France 24’s report on
France changing the 12-month deferral to a 4-month ban states that the policy shift “owes more
to medical progress than to changing attitudes towards homosexuality” (Dodman, 2019). This is
further demonstrated by the ultimate plan to bring donor conditions for MSM in line with
heterosexual donors pending relevant findings.
However, bills in the past to create criteria of exclusion based on high-risk behavior
instead of sexual orientation have been struck down by lawmakers in the French assembly. In
justification of this, France’s health ministry has states that donating blood is not a right and it is
a civic gesture that is subject to safety rules. Though, as discussed under “New Technologies,”
safety has not been a medical concern for MSM donors since the development of testing,
France’s governmental organizations continue to cite scientific evidence for their policy.
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“Our blood saves too” reads the Swiss Pink Cross’s webpage on blood donation. It is
nestled under the politics tab of their website. “Well, it’s only a political issue, because there is
no…evidence that MSM really have this much higher risk” (R. Heggli, personal communication,
April 12, 2022). In all three countries, the shift away from a complete ban of MSM donors came
after the political landscape shifted. Same-sex marriage was legalized, discrimination based on
sexual orientation was criminalized, and more national organizations came out declaring that
restrictions on the gay community were not medically founded.
Policy and politics go hand in hand. At the onset of the AIDS epidemic, when the bans
were instated, the policy was a result of political pressure. Likewise, easing the restrictions in the
2010s reflects changing political landscapes. It is clear, though, how policy can become a pawn
of political power. Roman describes how amending blood donation policy in Switzerland is a
relatively “easy” step in working towards equality for the gay community. Furthermore, the shift
to a 12-month deferral in all three countries was seen as an apprehensive step, one that was
driven by fear of political backlash instead of science. Again, both the creation and removal of
the MSM blood donation ban, was a result of mounting political pressure rather than a reaction
to new scientific knowledge.
However, of the countries described in this paper, as well as many other European
countries, Switzerland’s policy is considered one of the strictest with a 12-month deferral.
Roman, of the Pink Cross, boils this difference down to a “homophobic mindset” in the country.
There is the idea that gay sex is different, that gay men have a lot of sex and take on multiple
sexual partners at a given time. If this were a true assessment, it would be reasonable to conclude
that the MSM community is at a higher risk for HIV. However, the reality is that a lot of the
LGBTQ+ community are in long-term monogamous relationships. Therefore, the risk could be
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considered lower in the given population compared to a heterosexual woman with multiple
sexual partners, for example.
Someone with a risky sex life should avoid donating blood. However equating MSM
relationships with risky sex is a form of discrimination that is harmful to the LGBTQ+
community and results in policy creation that reflects perception rather than science and safety.
Additionally, according to the CDC, any form of sex has carried a risk factor for sexually
transmitted diseases (Karamitros, 2017). Requiring a period of abstinence for all donors for this
reason, though, has never been considered a possibility. Part of the reason is the necessity of
blood donations, and another part is the adequate testing available. Because policy and politics
go hand in hand, it is difficult to deny the influence of public perception and culture. This can
explain how MSM donors are regarded differently despite HIV being a disease that is blind to
sexual orientation.
The perception of homosexual relationships in the three different countries show that the
persistence of bans on MSM donors is indicative of perceptions of homosexual relationships.
However, there is not enough evidence to conclude that the perceptions impact the varying
policy between the three countries.
Another impact of culture on health policy is how a nation perceives “substantial”
information for change. Specifically, in Switzerland, the policy-making entities have continued
to cite a lack of evidence to lift strict restrictions on MSM donors despite an abundance of
studies and evidence from the global community. Switzerland can fund national studies and do
not feel the need to rely on other countries’ findings despite their validity. The requirement of
relying on original research within the country demonstrates how there is a certain standard
within Switzerland for medical research. However, other decisions for health policy have relied
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on evidence from other countries, such as the benefits of paternity leave, for example. Therefore,
there is potentially a mistrust of the MSM community within the country that can help explain
this discrepancy.

Conclusion
Though early bans on MSM blood donors have been analyzed to be reactionary and
created out of fear and political pressure, they were deemed necessary to protect national blood
supplies at the time. Changes to these policies did come in the countries observed in this paper
(The United States, France, and Switzerland), however there seemed to be factors outside of the
progression of science motivating decisions regarding MSM blood donors. As discussed, these
factors included historical context, new technologies, and public perception.
Both historical context and public perception seem to have delayed the change in policy
whereas new technologies provided opportunities for more equal treatment of MSM donors and
all other donors. Based on evidence in timelines, the delay between new technologies and policy
change were unjustified as the policy-making entities preferred historical context and public
perception over pure science in making decisions about MSM donors. Though there is no
significant evidence to suggest that historical context and public perceptions should not be
involved in health policy decisions, the clear disconnect from science in the decisions creates
discriminatory policy.
How did the current policies come into play? Why is the policy where it is right now? In
the United States, the current policy of a 3-month deferral was implemented recently, in 2020.
However, based on the FDA’s timing and recommendation, it seems clear that the change was a
result of the realization of the nationwide shortage of blood during the pandemic. Additionally,
mounting claims of the FDA’s policy being discriminatory from other organizations of means
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that the change was in part due to effective activism as well. The evidence provided by the new
policy as well as the evidence described throughout the paper demonstrates how the previous
restrictions were never really based on science.
Of the countries discussed in this paper, France is the only one to have moved away from
the discriminatory policy and shift towards restrictions that are based on risk behavior rather than
sexual orientation. By observing the timeline of change in France, however, this paper was able
to critically analyze why there was a delay in when individuals within policy-making entities
wanted to change policy and when the policy actually came into effect. Evidence points to the
fact that the delay is associated with the gathering of significant evidence. Though the origins
and persistence of the bans and restrictions on MSM are discriminatory in nature, the process by
which France brough policy change supports the concept of health policy decisions primarily
being based on the scientific process.
Roman Heggli, sees part of the reason Switzerland falls behind in changing policy for
MSM donors as that there is no need for more blood. Unlike the United States, there has not been
a significant concern about the supply of donated blood. As Switzerland’s policy-making entities
claim to be based on science, they continue to cite the lack of evidence supporting change.
However, the evidence exists based on the changes taken in many other western countries, the
data is just not from Switzerland. On the other hand, there have been no real efforts to conduct
the proper research to demonstrate this evidence, showing a lack of interest in the government to
make attempts to justify the restrictions beyond a blanket statement of insufficient evidence.
Overall, based on the theory presented by existing literature and the progression of policy
in the United States, France, and Switzerland, there is more than scientific knowledge that is
factored into health policy creation. Both the United States and Switzerland still rely on bans that
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are no longer scientifically valid. However, countries that have shifted to blood donation
restrictions based on risk behavior rather than individual identity demonstrate a shift. However,
this shift is not necessarily regarding new scientific knowledge, it may represent a shift in
perception and the understanding of historical context instead. In other words, health policy is
not solely based on scientific knowledge, historical context and perception play a significant
role. However, shifts in the biases held within historical understanding and public perception can
cause shifts in policy, which is what can be observed in relation to blood donation policy.

Abbreviation List
AIDS: Acquired Immunodeficiency Syndrome
BTS SRC: Blood Transfusion Service of the Swiss Red Cross Ltd
CDC: Centers for Disease Control
ELISA: Enzyme-Linked Immunosorbent Assay
FDA: Food & Drug Administration
HIV: Human Immunodeficiency Virus
LGBTQ+: Lesbian, Gay, Bisexual, Transexual, Queer
MSM: Men who have Sex with Men
NAT: Nucleic Acid Test
NIH: National Institute of Health
PEP: post-exposure prophylaxis
PrEP: pre-exposure prophylaxis
SpF: Santé publique France
SRC: Swiss Red Cross
US: the United States
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